Long-acting serotonin antagonist (Palonosetron) and the NK-1 receptor antagonists: does extended duration of action improve efficacy?

Anesthesiol Clin. 2014 Jun;32(2):505-16. doi: 10.1016/j.anclin.2014.02.004. Epub 2014 Apr 18.

Abstract

In a growing outpatient surgical population, postdischarge nausea and vomiting (PDNV) is unfortunately a common and costly anesthetic complication. Identification of risk factors for both postoperative nausea and vomiting and PDNV is the hallmark of prevention and management. New pharmacologic interventions with extended duration of action, including palonosetron and aprepritant, may prove to be more efficacious.

Keywords: Aprepitant; Casopitant; Nausea; Palonosetron; Postdischarge; Postoperative; Rolapitant; Vomiting.

Publication types

  • Review

MeSH terms

  • Antiemetics / therapeutic use*
  • Humans
  • Isoquinolines / therapeutic use*
  • Neurokinin-1 Receptor Antagonists / therapeutic use*
  • Palonosetron
  • Patient Discharge
  • Postoperative Nausea and Vomiting / drug therapy*
  • Quinuclidines / therapeutic use*
  • Serotonin Antagonists / therapeutic use*
  • Time Factors

Substances

  • Antiemetics
  • Isoquinolines
  • Neurokinin-1 Receptor Antagonists
  • Quinuclidines
  • Serotonin Antagonists
  • Palonosetron